Portfolio
Strategy
Team
News
Careers
Contact
Investor Login
Portfolio
Strategy
Team
News
Careers
Contact
CAMP4 Therapeutics Announces Dosing of First Participant in Phase 1 Clinical Study of CMP-CPS-001, a Potential First-in-Class Therapeutic for Urea Cycle Disorders
Read Article
News
2024
2023
Archive
Search news articles
October 6, 2016
VIVEVE® ANNOUNCES FDA 510(K) CLEARANCE FOR THE VIVEVE SYSTEM IN THE U.S.
September 21, 2016
CIDARA THERAPEUTICS SELECTS FIRST DEVELOPMENT CANDIDATE FROM ITS CLOUDBREAK™ IMMUNOTHERAPY DISCOVERY PLATFORM
September 19, 2016
FIERCEBIOTECH NAMES IDEAYA BIOSCIENCES AS ONE OF ITS “FIERCE 15” BIOTECH COMPANIES OF 2016
September 19, 2016
SCPHARMACEUTICALS ANNOUNCES PRESENTATIONS ON SUBCUTANEOUS FUROSEMIDE AT HFSA ANNUAL MEETING
September 15, 2016
HOMOLOGY MEDICINES ACQUIRES LICENSE TO NOVEL AAV TECHNOLOGY TO DEVELOP TREATMENTS FOR CENTRAL NERVOUS SYSTEM DISORDERS
September 8, 2016
CHRONO THERAPEUTICS RAISES $47.6 MILLION IN SERIES B FINANCING TO ADVANCE ITS CLINICAL PLATFORM FOR PERSONALIZED DRUG THERAPY
September 1, 2016
ACHAOGEN COMPLETES PATIENT ENROLLMENT IN PHASE 3 EPIC CLINICAL TRIAL OF PLAZOMICIN
August 31, 2016
AUDENTES THERAPEUTICS REPORTS SECOND QUARTER 2016 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
August 18, 2016
SPYRYX BIOSCIENCES EXPANDS EXECUTIVE TEAM, APPOINTS PULMONARY INDUSTRY LEADER, ALISTAIR WHEELER, MD, MFPM AS CHIEF MEDICAL OFFICER
August 17, 2016
AUDENTES THERAPEUTICS ANNOUNCES FIRST PATIENT ENROLLED IN THE INCEPTUS CLINICAL ASSESSMENT STUDY OF XLMTM
« Previous Page
1
…
90
91
92
93
94
…
118
Next Page »